Scott Brun
Director/Board Member bei CABALETTA BIO, INC.
Vermögen: - $ am 31.03.2024
Profil
Scott Brun is currently serving as a Director at Axial Therapeutics, Inc., Independent Director at Cabaletta Bio, Inc., and Independent Director at Forte Biosciences, Inc. He is also a Director at Trishula Therapeutics, Inc. and Jasper Therapeutics, Inc. Additionally, he is a Venture Partner at Abingworth Management, Inc. and serves on the Advisory Board of Accelerator Services Corp.
He is the President of Gold Mast Consulting, LLC.
Previously, he worked as the Head of Clinical Development at Abbott Laboratories and as the Vice President of Clinical Development at AbbVie, Inc. He holds a doctorate degree from The Johns Hopkins University School of Medicine and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CABALETTA BIO, INC.
-.--% | 04.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
FORTE BIOSCIENCES INC.
-.--% | 19.09.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Scott Brun
| Unternehmen | Position | Beginn |
|---|---|---|
| CABALETTA BIO, INC. | Director/Board Member | 24.06.2021 |
| FORTE BIOSCIENCES, INC. | Director/Board Member | 10.11.2022 |
| JASPER THERAPEUTICS, INC. | Director/Board Member | 20.06.2023 |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Director/Board Member | 12.02.2020 |
| Gold Mast Consulting, LLC | President | - |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Director/Board Member | - |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Private Equity Investor | - |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Scott Brun
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Scott Brun
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBVIE INC. | Health Technology |
| CABALETTA BIO, INC. | Health Technology |
| FORTE BIOSCIENCES, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Private Unternehmen | 5 |
|---|---|
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Health Technology |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Health Technology |
| Gold Mast Consulting, LLC |
